Starsource Multitrade (506365) Q4 10/11 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 10/11 earnings summary
21 Oct, 2026Executive summary
Manufacturing remained suspended; activity focused on share trading and other investments while new business opportunities were explored. Income rose to Rs. 363,063 from Rs. 101,936, and profit after tax was Rs. 35,150 versus a prior-year loss of Rs. 511,936.
Accounts were prepared on a going-concern basis despite suspended operations; the auditor highlighted unprovided investment diminution and a doubtful deposit, alongside the going-concern assumption.
Financial highlights
Income was Rs. 363,063 in FY2010-11 versus Rs. 101,936 in FY2009-10; total expenditure was Rs. 215,176 versus Rs. 534,682.
Profit before and after tax was Rs. 35,150, compared with a loss of Rs. 511,936 in FY2009-10; depreciation was Rs. 112,737 versus Rs. 79,190.
Total assets and liabilities were Rs. 71.90m, up from Rs. 67.61m; investments were Rs. 28.31m versus Rs. 19.78m, while accumulated losses were Rs. 30.23m.
Outlook and guidance
New business avenues were being explored; surplus funds were held in liquidatable investments to meet potential capital requirements for a new business.
Management cautioned that forward-looking expectations may differ materially from actual results and undertook no obligation to update them.
Latest events from Starsource Multitrade
- Tax write-back lifted net profit as factory operations restarted and Fine Chemicals trials advanced.506365
Q4 96/97 - A continuing factory lockout and Rs. 83,23,334 pre-tax loss defined the year.506365
Q4 97/98 - Continued lockout, Rs.4.488m net loss, and major unprovided liabilities and investment impairment.506365
Q4 98/99 - Lockout and a widening Rs.4.38m loss drove plans to explore disposal or leasing.506365
Q4 04/05 - Lockout halted operations; FY2002-03 net loss was Rs.863,221 as leasing talks continued.506365
Q4 02/03 - Manufacturing ceased after asset sales; diversification and material financial risks remain.506365
Q4 06/07 - Manufacturing stayed halted; FY08 PAT fell to Rs 0.08 lakh as diversification remained uncertain.506365
Q4 07/08 - Suspended manufacturing, falling income and auditor-flagged asset and loan risks defined FY10.506365
Q4 09/10 - Investment-sale income drove FY12 profit as manufacturing remained suspended.506365
Q4 11/12